Each year, over 1 million Americans experience a nonfatal or fatal myocardial infarction or sudden death from coronary heart disease (CHD) [1]. Unfortunately, death or myocardial infarction is the first symptom in 55% of patients with coronary artery disease [2] and is usually due to dislodgement of a plaque causing acute coronary occlusion. However, about 30% of these patients present with ischemia and have concurrent chest pain. In these individuals, exercise treadmill testing is a practical and the most commonly performed test to identify or confirm the presence of latent coronary artery disease [2]. In addition, an abnormal test has been shown to have definite predictive value. It is well known that when symptoms of typical angina are present, coronary disease can be predicted with considerable reliability. Even when there is no history of pain, there is still a strong possibility of significant coronary disease in patients with specific risk factors. Also, the reliability of the test in asymptomatic patients is improved when testing patients with a higher prevalence of the disease.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Fowler-Brown A, Pignone M, Pletcher M, et al. Exercise tolerance testing to screen for coronary heart disease: A systematic review for the technical support for the U.S. preventive services task force. Ann Intern Med. 2004;140:W9—W24.
Ellestad MH. Stress testing: Principles and practice, 5th ed. Oxford University Press. 2003.
Thaulow E, Erikssen J, Sandvik L, Erikssen G, Jorgensen L, Cohn PF. Initial clinical presentation of cardiac disease in asymptomatic men with silent myocardial ischemia and angiographically documented coronary artery disease (the Oslo Ischemia Study). Am J Cardiol. 1993;72:629—633.
Institute for clinical systems improvement. Health Care Guideline: Cardiac Stress Test Supplement, 6th ed. 2004.
Froelicher VF, Myers JN. Exercise and the Heart, 5th ed. Philadelphia, Elsevier, Inc.,2006, 15.
Diabetes mellitus and exercise. ADA standards of medical care in diabetes—2007. Diabetes Care. 2007;30:S4—S41.
Stuart RJ, Ellestad MH. National survey of exercise stress testing facilities. Chest. 1980;77:94—97.
Gibbons RJ, Balady GJ, Bricker JT, et al. American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). ACC/AHA 2002 guideline update for exercise testing: summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Circulation. 2002;106:1883—1892.
American College of Sports Medicine. Guidelines for Exercise Testing and Prescription, 6th ed. Baltimore, Lippincott Williams & Wilkins, 2000, 26.
ACC/AHA 2002 Guideline Update for Exercise Testing. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). Circulation J Am Coll Cardiol. 2002.
Fletcher GF, Froelicher VF, Hartley LH, Haskell WL, Polluck ML. Special report of exercise standards: A statement for health professionals from the American Heart Association. Circulation. 1990;82:2286—2322.
De Ponti C, De Biase AM, Cataldo G, et al. Effects of nifedipine, acebutolol, and their association on exercise tolerance in patients with effort angina. Cardiology. 1981;68:195—199.
Fox KM, Deanfield J, Jonathan A, et al. The dose-response effects of nifedipine on ST- segment changes in exercise testing: Preliminary studies. Cardiology. 1981;68:209—212.
Sundqvist K, Atterhog JH, Jogestrand T. Effect of digoxin on the electrocardiogram at rest and during exercise in healthy subjects. Am J Cardiol. 1986;57:661—665.
Gibbons RJ, Balady GJ, Beasley JW, et al. ACC/AHA guidelines for exercise testing: A report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines (Committee on Exercise Testing). J Am Coll Cardiol. 1997;30:260—315.
Smith RB, Rusbatch BJ. Amitriptyline and heart block. Br Med J. 1967;3:311.
Vohra J, Burrows GD, Sloman F. Assessment of cardiovascular side effects of therapeutic doses of tricyclic anti-depressant drugs. Aust NZ J Med. 1975;5:7—11.
Wilson WM, Maughan RJ. Evidence for a possible role of 5-hydroxytryptamine in the genesis of fatigue in man: Administration of paroxetine, a 5-HT re-uptake inhibitor, reduces the capacity to perform prolonged exercise. Exp Physiol. 1992;77:921—924.
Fagard R, Amery A, Reybrouck T, et al. Effects of angiotensin antagonism on hemodynamics, renin, and catecholamines during exercise. J Appl Physiol. 1977;43:440—444.
Pickering TG, Case DB, Sullivan PA, et al. Comparison of antihypertensive and hormonal effects of captopril and propranolol at rest and during exercise. Am J Cardiol. 1982;49:1566—1568.
Dickstein, K, et al. Comparison of the effects of losartan and enalapril on clinical status and exercise performance in patients with moderate or severe chronic heart failure. J Am Coll Cardiol. 1995;26:438.
Hamroff, G, et al. Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure. Circulation. 1999;99:990.
Niederberger M, Bruce RA, Kusumi F, et al. Disparities in ventilatory and circulatory responses to bicycle and treadmill exercise. Br Heart J. 1974;36:377.
Wasserman K, Hansen JE, Sue DY, Stringer WW, Whipp BJ. Principles of Exercise Testing and Interpretation, 4th ed. Lippincott Williams & Wilkins. 2005.
ACC/AHA Guideline Revision. ACC/AHA 2007 Guidelines for the Management of Patients with Unstable Angina/Non–ST-Elevation Myocardial Infarction—Executive Summary. J Am Coll Cardiol. 2007;50:652—726.
Borg GA. Psychophysical bases of perceived exertion. Med Sci Sports Exerc. 1982;14:377—381.
Borg G. Perceived exertion as an indicator of somatic stress. Scand J Rehabil Med. 1970;23:92—93.
Borg G, Holmgren A, Lindblad I. Quantitative evaluation of chest pain. Acta Med Scand. 1981;644:43—45.
Will PM, Walter JD. Exercise testing: Improving performance with a ramped Bruce protocol. Am Heart J. 1999;138:1033—1037.
Rice, KR, et al. Effects of nifedipine on myocardial perfusion during exercise in chronic stable angina pectoris. Am J Cardiol. 1990;65:1097.
Michaelides AP, Psomadake ZD, Divaveris PE, et al. Improved detection of coronary artery disease by exercise electrocardiography with the use of right precordial leads. N Engl J Med. 1999;340:340—345.
White RD, Evans EH. Performing the exercise test. Primary Care. 2001;28(1):44.
Cole CR, Blackstone EH, Pashkow FJ, et al. Heart-rate recovery immediately after exercise as a predictor of mortality. N Engl J Med. 1999;341:1351—1357.
Lachterman B, Lehmann KG, Abrahamson D, Froelicher VF: “Recovery only” ST segment depression and the predictive accuracy of the exercise test. Ann Intern Med. 1990;112:11—16.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this chapter
Cite this chapter
Harris, G.D., White, R.D. (2009). Performance of the Exercise Test. In: Evans, C.H., White, R.D. (eds) Exercise Stress Testing for Primary Care and Sports Medicine. Springer, New York, NY. https://doi.org/10.1007/978-0-387-76597-6_2
Download citation
DOI: https://doi.org/10.1007/978-0-387-76597-6_2
Publisher Name: Springer, New York, NY
Print ISBN: 978-0-387-76596-9
Online ISBN: 978-0-387-76597-6
eBook Packages: MedicineMedicine (R0)